TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 303 filers reported holding TANDEM DIABETES CARE INC in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $382,147 | -14.2% | 18,399 | +1.4% | 0.00% | -25.0% |
| Q2 2023 | $445,327 | -41.1% | 18,147 | -2.6% | 0.00% | -42.9% |
| Q1 2023 | $756,564 | -7.1% | 18,630 | +2.8% | 0.01% | -12.5% |
| Q4 2022 | $814,539 | -2.1% | 18,121 | +4.3% | 0.01% | -11.1% |
| Q3 2022 | $832,000 | -18.8% | 17,382 | +0.4% | 0.01% | -10.0% |
| Q2 2022 | $1,025,000 | -48.7% | 17,309 | +0.8% | 0.01% | -37.5% |
| Q1 2022 | $1,997,000 | -21.8% | 17,174 | +1.2% | 0.02% | -15.8% |
| Q4 2021 | $2,553,000 | +25.3% | 16,964 | -0.6% | 0.02% | +11.8% |
| Q3 2021 | $2,037,000 | +23.1% | 17,062 | +0.4% | 0.02% | +30.8% |
| Q2 2021 | $1,655,000 | +9.0% | 16,991 | -1.2% | 0.01% | 0.0% |
| Q1 2021 | $1,518,000 | -5.5% | 17,200 | +2.5% | 0.01% | -13.3% |
| Q4 2020 | $1,606,000 | -17.9% | 16,780 | -2.6% | 0.02% | -21.1% |
| Q3 2020 | $1,955,000 | +54.3% | 17,228 | +34.5% | 0.02% | +5.6% |
| Q2 2020 | $1,267,000 | +57.8% | 12,807 | +2.6% | 0.02% | +28.6% |
| Q1 2020 | $803,000 | – | 12,486 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
| Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
| First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
| Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
| EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
| Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
| Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
| Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
| Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |